Pharmarise Holdings Corporation

2796.T
Pharmaceutical Retailers
2026/07/22 Updated
Market Cap: $34.5M (¥5.6B)
Stock Price: $3.00 (¥489)
Exchange Rate: 1 USD = ¥163.13

Notice of Dividend Decision for FY 8 (Reiwa 8) | Continuing Shareholder Returns

PharmaRise Holdings has decided on a final dividend of 14 yen per share for FY 8 (Reiwa 8), with the formal resolution scheduled at the shareholders meeting on August 28. The total dividend amount is 161 million yen, continuing its policy of shareholder returns.

Importance:
Page Updated: July 23, 2026
IR Disclosure Date: July 23, 2026

Key Figures

  • Dividend Amount: 161 million Yen
  • Dividend per Share: 14 Yen
  • Effective Date: August 31, Reiwa 8

AI要約

Performance Overview

PharmaRise Holdings has decided on a dividend of 14 yen per share for FY 8 (Reiwa 8). The total dividend amount will be 161 million yen, with a policy of stable shareholder returns. The effective date of the dividend is August 31, Reiwa 8, emphasizing profit sharing with shareholders as a key management policy.

Future Outlook and Impact on Shareholders

The company aims for continuous profit distribution by considering overall performance and dividend payout ratio. Shareholders can expect stable dividends, contributing to long-term asset formation. The official decision at the 40th Ordinary General Meeting of Shareholders will confirm the dividend payment.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

PharmaRise Holdings Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →